ETFs

ETF News

20 stories
globenewswire

Adeia Enters into Multi-Year IP License Agreement with RPX

Agreement provides select RPX members access to Adeia's media IP portfolio to support intelligent e-commerce experiencesSAN JOSE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. NASDAQ:ADEA, the technology company known for developing innovations that enable next-generation solutions for the s…

GlobeNewswire en
ETFsStocksUS
globenewswire

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated safety profile for AdvSM patientsAPEX NDA is third submission for bezuclastinib in six months; PEAK a…

GlobeNewswire en
ETFsStocksUS
globenewswire

Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1

GeneTAC® small molecule designed to selectively reduce transcription of the mutant DMPK allele and address the underlying cause of DM1CARLSBAD, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. NASDAQ:DSGN, a clinical-stage biotechnology company developing treatments for serious d…

GlobeNewswire en
ETFsStocksUS
globenewswire

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from Phase 2 VIRO-15 trial -- Data demonstrate Olvi-Vec–mediated modulation of the tumor microenvironment and immune activation -- Translational analyses ident…

GlobeNewswire en
ETFsStocksUS
modular_finance

Invitation to the presentation of Mycronic’s Q2 2026

Analysts, investors and media are invited to the presentation of Mycronic’s Q2 2026. The presentation will be held on July 14, 2026, at 10:00 a.m. CEST. The report is published on July 14, 2026, at 8:00 a.m. CEST and will, together with the presentation and webcast, be available via Mycronic’s repo…

MFN by Modular Finance en
ETFsStocksSE
globenewswire

Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease

WILMETTE, Ill., June 30, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) NASDAQ:MNPR, a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) h…

GlobeNewswire en
ETFsStocksUS

PowerBank Secures 21-Megawatt Operations and Maintenance Agreement with Honeywell for 3 Community Solar Projects in New York State

Agreement confirmed following the successful commercial operation of the SB 13-2 project developed by PowerBank Corporation under an Engineering, Procurement and Construction agreementTORONTO, June 30, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ:PBK) (Cboe CA: PBK) (FSE: 103) ("PowerBank" or…

PR Newswire en
ETFsStocksUS